The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 26, 2022

Filed:

May. 22, 2021
Applicant:

Somerset Therapeutics, Llc, Hollywood, FL (US);

Inventors:

Mandar V Shah, Rockaway, NJ (US);

Veerappan Subramanian, Warren, NJ (US);

Ilango Subramanian, Warren, NJ (US);

Ojas Prakashbhai Doshi, Somerville, NJ (US);

Assignee:

SOMERSET THERAPEUTICS, LLC., Hollywood, FL (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/7036 (2006.01); A61K 9/00 (2006.01); A61K 47/18 (2017.01); A61K 47/54 (2017.01); A61P 27/02 (2006.01); A61P 31/04 (2006.01); A61K 31/573 (2006.01); A61K 47/34 (2017.01); A61K 47/60 (2017.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7036 (2013.01); A61K 9/0048 (2013.01); A61K 31/573 (2013.01); A61K 45/06 (2013.01); A61K 47/183 (2013.01); A61K 47/34 (2013.01); A61K 47/545 (2017.08); A61K 47/60 (2017.08); A61P 27/02 (2018.01); A61P 31/04 (2018.01);
Abstract

Disclosed herein are new compositions comprising (1) an antibacterial component comprising (a) a complex comprising (i) an active pharmaceutical ingredient (API) wherein the active pharmaceutical ingredient is tobramycin, a similar compound, or a derivative of either thereof and (ii) a complexing agent, or (b) a derivative of tobramycin or a similar compound comprising one or more conjugates/derivatizing groups, wherein the complexing agent or conjugate(s) cause a detectable increase in API permeation of corneal cells, retention in corneal cells, or both, as compared to the non-complexed or non-derivatized API, and (2) an effective amount of an anti-inflammatory agent, such as dexamethasone or another dexamethasone compound. This disclosure also describes new methods of using such compositions, producing such compositions, and the like.


Find Patent Forward Citations

Shah, Mandar. (2022). Combination products of tobramycin compounds and dexameihasone compounds (U.S. Patent No. 11395831). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11395831

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…